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ABSTRACT: Amphiphilic self-assembling peptides are func-
tional materials, which, depending on the amino acid
sequence, the peptide length, and the physicochemical
conditions, form a variety of nanostructures including
nanovesicles, nanotubes, and nanovalves. We designed lipid-
like peptides with an aspartic acid or lysine hydrophilic head
and a hydrophobic tail composed of six alanines (i.e., ac-A6K-
CONH2, KA6-CONH2, ac-A6D-COOH, and DA6-COOH).
The resulting novel peptides have a length similar to biological
lipids and form nanovesicles at physiological conditions. AFM microscopy and light scattering analyses of the positively charged
lipid-like ac-A6K-CONH2, KA6-CONH2 peptide formulations showed individual nanovesicles. The negatively charged ac-A6D-
COOH and DA6-COOH peptides self-assembled into nanovesicles that formed clusters that upon drying were organized into
necklace-like formations of nanovesicles. Encapsulation of probe molecules and release studies through the peptide bilayer
suggest that peptide nanovesicles may be good candidates for sustained release of pharmaceutically active hydrophilic and
hydrophobic compounds. Lipid-like peptide nanovesicles represent a paradigm shifting system that may complement liposomes
for the delivery of diagnostic and therapeutic agents.
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■ INTRODUCTION
Molecular self-assembly has enabled the fabrication of
nanostructures and the development of advanced functional
materials.1 The design and synthesis of biologically inspired
molecules with self-assembling properties has signiﬁcantly
advanced the ﬁeld of biomaterials and includes peptide,
oligonucleotide, and polysaccharide systems.2 Depending on
the amino acid sequence, self-assembling peptides have varying
properties and have been tested in biomedicine as permissive
biological scaﬀolds for regenerative medicine and drug
delivery.3−8 These short, self-assembling peptides are non-
toxic, non-immunogenic, and degrade to natural amino acids
which can be physiologically metabolized.
Self-assembly of amphiphilic lipid-like peptides leads to the
formation of stable nanotubes, nanodoughnuts, nanovalves,
nanovesicles, or micelles similar to lipids and chemical
surfactants.9 The type and size of the self-assembled peptide
nanostructures depend on the peptide concentration, the
peptide speciﬁc critical micelle concentration (CMC), the
amino acid sequence, geometrical constraints (deﬁned by the
size of the amino acid side groups), the ionic strength, and the
pH of the medium.9,10 These factors aﬀect peptide alignment,
packing density, and strength of the intermolecular interactions
between the monomers, which determine the formation of
hierarchical supramolecular structures of diﬀerent morpholo-
gies and properties.9,11 Since their discovery in 2002,9 self-
assembling lipid-like peptides have been studied by many
groups; these studies improved our understanding and
highlighted the importance of the system.12−16 The develop-
ment of lipid-like self-assembling peptides with surfactant
properties has opened new avenues for applications in
biotechnology for the stabilization of membrane proteins
more eﬀectively than commercial detergents11,17,18 and in
nanotechnology for the construction of energy conversion
devices.19
Lipid-like self-assembling peptides are amenable to molecular
design allowing modiﬁcations in the number, type, and order of
amino acids on the peptide chain as well as incorporation of
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active peptide sequences to facilitate cell penetration or reactive
chemical groups such as ﬂuorescent dyes or biotin. The ease of
production and the wide scope of modiﬁcation allow for the
synthesis of designer sequences with “tailor-made” tunable
properties. In this work, we set out to investigate the
physicochemical of cationic and anionic lipid-like peptides,
and determine the release kinetics of model drug compounds
through peptide formulations as a ﬁrst step towards the
development of a peptide-based drug delivery system.
■ MATERIALS AND METHODS
Lipid-like Self-Assembling Peptides. Ac-A6K-CONH2, KA6-
CONH2, ac-A6D-COOH, and DA6-COOH were received in powder
(SynBioSci, Livermore, CA). The purity of the peptides was 90−94%
as determined by electrospray ionization-quadrupole-time-of-ﬂight
(ESI-Q-TOF) mass spectrometry. Peptides were dispersed in PBS pH
7.4, probe sonicated for 10 min to facilitate dispersion, and
equilibrated for 15 min to allow for self-association of the monomers.
CMC of Lipid-like Peptides. DLS was used to determine the
peptides’ CMC (PDDLS/Batch setup, Precision Detectors, Franklin,
MA). Solutions of diﬀerent peptide concentrations in PBS pH 7.4
were ﬁltered through 0.45 μm pore size ﬁlters prior to measuring.
Scattered light was detected at 90° and the number of photons was
recorded and processed by Precision Deconvolve. The solvent
viscosity and the refractive index of the buﬀer were taken as 0.894
cP and 1.33, respectively, at 25 °C.
Particle Size Determination. Normalized intensity (I)−time (t)
autocorrelation functions g(2)(q,t) = ⟨I(q,t)I(q,0)⟩/⟨I(q,0)⟩2 of the
peptide vesicle dispersions in PBS at 25 °C were measured (n ≥ 4)
over a broad time scale (10−7−104 s) using a full multiple τ digital
correlator with 280 channels spaced quasi-logarithmically (ALV−
5000/FAST) and the 671 nm line of a diode pumped solid state laser
(operated at a power <5 mW). The scattered light was collected by a
single-mode optical ﬁber, transferred to an avalanche photo-detector
and then to the digital correlator for analysis. In dilute suspensions, the
normalized electric ﬁeld (E)−time autocorrelation function g(1)(q,t) =
⟨E(q,t)E*(q,0)⟩/⟨E(q,0)⟩2 is related to the experimentally recorded
g(2)(q,t)2 through the Siegert relation:20 g(2)(q,t) = B[1 + f*|g(1)(g,t)|2]
where B describes the long delay time behavior of g(2)(q,t) and f* is an
instrumental factor (in our system f* ∼ 0.95). Hence, g(1)(t) (for
simplicity we drop the q-dependence) was analyzed as a weighted sum
of independent exponential contributions g(1)(t) = ∫ L(τ) exp(−t/τ)dτ
= ∫ L(ln τ) exp(−t/τ)d ln τ. The distribution of relaxation times L(ln
τ) = τL(τ) was obtained by inverse Laplace transformation of g(1)(q,t)
using the CONTIN algorithm.21 The apparent hydrodynamic radii of
the suspended particles were determined using the Stokes−Einstein
relation Rh = kBT/6πηD, where kB is the Boltzmann constant, η is the
viscosity of the solvent, and D is the diﬀusion coeﬃcient of the particle
which is equal to D = (1/τ)q2, where τ is the relaxation time of
g(1)(q,t).
AFM of Peptide Nanovesicles. 3 μL of the peptide vesicle
dispersions (20 mg/mL of peptides in PBS ﬁltered through 0.45 μm
ﬁlters) were deposited on mica (G250-2, rms ∼ 0.4 nm; Agar Scientiﬁc
Ltd, Essex, U.K.), rinsed with 200 μL of water (Millipore) after 1 min
of equilibration and dried in nitrogen gas stream for 5 min or in air for
1 h. Images were obtained immediately in air using a Bruker
MultiMode NanoScope 3D Controller Scanning Probe Microscope
(Digital Instruments) operated in tapping mode and soft silicon
probes (FESP; nominal length lnom = 225 μm, width wnom = 28 μm, tip
radius Rnom = 8 nm, resonant frequency υnom = 75 kHz, spring constant
knom = 2.8 N m
−1; Veeco Instruments SAS, France). Images were
collected from two samples of each peptide system at random spot
surface sampling (at least eight areas).
Release through Peptide Nanovesicles. Peptides in powder
were mixed to a ﬁnal concentration of 5 mg/mL with 1 mM CF
solution in PBS and the suspension was probe-sonicated for 10 min.
After equilibration for 1 h, 1 mL of the nanovesicle suspension was
placed in Microcon YM-10 membrane tubes (10 kDa cut-oﬀ). Non-
encapsulated CF was removed by centrifugation at 11 000 rpm for 20
min. Then the vesicles were re-suspended in PBS pH 7.4 to a ﬁnal
volume of 1 mL and were incubated at 25 °C. CF released through
peptide nanovesicles (n = 4) was collected by centrifugation of the
membrane tubes at 11 000 rpm for 20 min, the ﬂuorescence intensity
of the ﬁltrate was measured, fresh PBS pH 7.4 was added to a ﬁnal
volume of 1 mL, and the suspension was incubated. This process was
repeated at speciﬁc time points, and a graph was created to show the
time course of released CF through peptide nanovesicles. All
measurements were carried out in a PerkinElmer LS-50B spectropho-
tometer using 1 cm quartz cuvettes. The excitation wavelength was at
470 nm, and the emission maximum was observed at 520 nm.
Nile red was used as model compound to study the uptake of
hydrophobic molecules by lipid-like peptide nanovesicles. Peptide
powder (5 mg) was added to 1 mL PBS pH 7.4 containing 3.14 μM
Nile red (i.e., maximum concentration of Nile red in water),25 the
suspension was probe sonicated for 10 min, placed in Microcon YM-
10 membrane tubes (n = 4) and incubated at 25 °C. To determine the
release kinetics we measured ﬂuorescence intensity of the peptide
nanovesicle suspension, removed the released Nile red by
centrifugation of the membrane tubes at 11 000 rpm for 20 min and
added fresh PBS pH 7.4 to 1 mL. This process was repeated at speciﬁc
time points. Fluorescence emission was recorded from 550 to 700 nm
using 1 cm quartz cuvettes (excitation was at 545 nm).
Eﬀect of Lipid-like Peptides on Cell Viability. Caco-2 cells
(passage 40) were cultured at 37°C in growth medium (i.e., DMEM,
supplemented with 10% v/v FBS, 1% w/v non-essential amino acids
and 100 μg/mL penicillin and streptomycin) in 5% v/v CO2
humidiﬁed atmosphere. The medium was changed every 2−3 days
until cells reached 80% conﬂuency in culture, and then, cells were
trypsinized and subcultured. The eﬀect of lipid-like peptides on cell
viability and proliferation was studied using the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium (MTT) assay (Trevigen Inc., MD).
Caco-2 cells grown to a density of 4 × 103 cells/cm2 in 96-well plates
were incubated for 3 and 24 h in growth medium containing 0.2 or 1.0
mg/mL of lipid-like peptides. Then, 10 μL of MTT reagent were
added, and the plates were incubated for 3 h at 37 °C. Absorbance of
the formazan product was determined at 600 nm with a Teknika
ELISA plate reader after 1 h.
■ RESULTS AND DISCUSSION
A class of self-assembling peptides (i.e., ac-A6K-CONH2, KA6-
CONH2, ac-A6D-COOH, and DA6-COOH) was designed to
mimic lipids of biological membranes. These peptides have a
hydrophobic tail composed of six alanines, a hydrophilic head,
which is an amino acid with charged side group and a length of
∼2.5 nm (Figure 1). As lipid-based systems, addition of lipid-
like peptides to water or an electrolyte solution results in
formation of a turbid suspension due to self-assembly of the
peptide monomers to minimize the interaction between
hydrophobic domains and polar environment.9 We determined
the CMC of lipid-like peptides in phosphate buﬀer saline (PBS,
100 mM KH2PO4, 10 mM Na2HPO4, 137 mM NaCl, 2.7 mM
KCl at pH 7.4) to be 0.12 mg/mL for A6K-CONH2, 0.09 mg/
mL for KA6-CONH2, 0.08 mg/mL for ac-A6D-COOH, and
0.06 mg/mL for DA6-COOH.
Atomic Force Microscopy (AFM) Imaging. We used
AFM to study the morphology of lipid-like peptide assemblies.
Previously, we reported that self-assembly of lipid-like peptides
results in uncontrolled formation of various supramolecular
structures including vesicles, micelles, and nanotubes.9,10
Herein, the experimental conditions typically resulted in
nanovesicle formation (Figure 2). Size distribution analyses of
the peptide nanovesicles showed that self-assembly of the
lysine-containing, positively charged ac-A6K-CONH2 and KA6-
CONH2 peptides results in larger particles (126 and 169 nm,
respectively) compared to those observed from association of
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the negatively charged ac-A6D-COOH and DA6-COOH (28
and 44 nm, respectively) (Table 1, Figure 2 insets). This is due
to the smaller side chain of aspartic acid compared to lysine,
which allows for better packing of ac-A6D-COOH and DA6-
COOH peptides in the nanovesicle bilayer as suggested
previously by molecular modeling studies.9
AFM imaging of ac-A6D-COOH and DA6-COOH peptide
assemblies revealed dispersed nanovesicles as well as necklace-
like ultra-structures (Figure 2 C−D). Such formations are
observed at the micrometer scale in colloidal systems, when a
drop of the suspension evaporates on a solid surface and have
been described by two dimensional crystallization laws,22 or the
coﬀee-ring eﬀect.23 It may be that such phenomena are
reproduced at the nanometer scale due to evaporation of the
solvent and repulsion of like-charged peptide nanovesicles. The
diameter of necklaces composed of ac-A6D-COOH and DA6-
COOH nanovesicles is 200 and 159 nm, respectively (Table 1).
Image analysis showed that ac-A6D-COOH necklaces have 20
± 5 individual (average diameter 28 nm) ac-A6D-COOH
nanovesicles per necklace whereas necklaces composed of
larger (average diameter 44 nm) DA6-COOH nanovesicles
have 9 ± 3 nanovesicles per necklace.
These observations prompted inquiry about the mechanism
of necklace formation. Changing the sample drying conditions
(from quick nitrogen gas drying to slow air drying for 1 h)
revealed metastable nanovesicle clusters (Figure 2 E−F)
suggesting that prior to necklace formation ac-A6D-COOH
and DA6-COOH peptide nanovesicles formed loosely bound
clusters with diameter 113 and 135 nm, respectively. It is likely
that during quick sample drying under nitrogen gas the
negatively charged peptide nanovesicle clusters disassemble and
spread on the like-charged mica surface leading to nanovesicle
necklace-like formations. Theoretical calculations assuming
tight packing of hard spheres, revealed that 20 ac-A6D-
COOH nanovesicles with diameter 28 nm and 9 DA6-
COOH nanovesicles with diameter 44 nm form clusters with
diameter 97 and 120 nm, respectively.24 These values correlate
well with the AFM determined sizes of the ac-A6D-COOH (i.e.,
113 nm) and DA6-COOH (i.e., 135 nm) nanovesicle clusters.
Dynamic Light Scattering (DLS). The hydrodynamic
radii, Rh, of the peptide nanovesicle suspensions were
determined by DLS from which the intensity-time correlation
functions and the corresponding inverse Laplace transform
analyses of lipid-like peptide nanovesicles in PBS were
calculated (Figure 3). Analysis of the light scattering data
yielded monomodal peptide vesicle size distributions except in
the case of KA6-CONH2 suspensions in which peak analysis
showed the presence of particles with average diameter of 164
and 906 nm; the latter probably represent aggregates of
individual nanovesicles.
DLS measurements of the ac-A6K-CONH2 and KA6-CONH2
nanovesicle diameter are in agreement with the size of mica
deposited nanovesicles as determined by AFM. However, DLS
analysis of ac-A6D-COOH and DA6-COOH peptide nano-
vesicle suspensions revealed the presence of particles with
diameter 99 and 137 nm, respectively (Figure 3). These values
deviate from the nanovesicle diameter determined by AFM for
dispersed ac-A6D-COOH and DA6-COOH nanovesicles but
Figure 1. Molecular modeling, amino acid sequence, and charge
distribution of lipid-like self-assembling peptides. The peptide length is
similar to biological phospholipids. The hydrophobic domain of the
peptides consists of six alanines. Color code: cyan, carbon; red,
oxygen; blue, nitrogen; white, hydrogen. Illustrations were generated
by VMD. Highlighted domains represent amino acids with positive
charge (blue), negative charge (red), and hydrophobic side chains
(grey). Using pKa values from the literature the net charge of the
peptides at pH 7.4 was calculated to be ac-A6K-CONH2 (+1), KA6-
CONH2 (+2), ac-A6D-COOH (−2), DA6-COOH (−1).
Figure 2. AFM of lipid-like peptide nanovesicles on mica. (A−D
Insets) size distribution histograms of peptide nanovesicles were
generated from AFM image analysis. (C and D) ac-A6D-COOH and
DA6-COOH peptide nanovesicle necklace-like formation upon quick
drying of the samples under nitrogen gas. (C and D Insets) ImageJ
image processing showing the surface topology of the necklace-like
formations. (E and F) ac-A6D-COOH and DA6-COOH peptide
nanovesicle clusters formed upon slow air drying of the samples. (E
and F Insets) Graphical representation of 20 and 9 tightly packed ac-
A6D-COOH and DA6-COOH nanovesicles was generated by http://
www.randomwalk.de/sphere/insphr/spheresinsphr.html.
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resemble the size of the nanovesicle clusters suggesting that
these clusters are stable in PBS in which DLS measurements
were performed (Table 1, Figure 3). Nanovesicle cluster
spreading on the mica surface accounts for the higher cluster
diameter determined by AFM compared with that of the DLS
analysis.
The hydrodynamic diameter of the nanovesicles (Table 1)
appears to be slightly smaller than that measured by AFM
which may be due to slight deformation of the nanovesicles
caused by adsorption on the mica surface and/or AFM tip
broadening eﬀects. Therefore, the size of the nanovesicles
measured by AFM (dry state) correlates well with the
hydrodynamic diameter determined by DLS. This suggests
that nanovesicle shrinking is negligible during drying that
precedes AFM scanning.
Release of Hydrophilic Molecules through Peptide
Nanovesicles. To determine whether peptide nanovesicles
can be used in drug delivery applications, we measured the
release kinetics of the hydrophilic ﬂuorescent probe CF
through the vesicle bilayer. Encapsulated CF is strongly
quenched, and therefore, only the released CF contributes to
the ﬂuorescence emitted. Figure 4A shows that positively
charged ac-A6K-CONH2 peptide nanovesicles retained CF
entrapped for more than 6 h whereas negatively charged ac-
A6D-COOH nanovesicles released CF in ∼3 h. Nanovesicles
composed of the positively charged KA6-CONH2 and the
negatively charged DA6-COOH peptides released CF within
∼1 h.
This suggests that electrostatic interactions do not aﬀect CF
encapsulation and release through the nanovesicles because (i)
the less positively charged ac-A6K-CONH2 nanovesicles
retained the negatively charged CF better than the more
positively charged KA6-CONH2 nanovesicles (KA6-CONH2
carries two positive charges while ac-A6K-CONH2 peptide
has one positive charge, Figure 1) and (ii) the negatively
charged DA6-COOH nanovesicles did not retain CF better
compared to the more negatively charged ac-A6D-COOH
nanovesicles (DA6-COOH overall carries one negative charge
at the C-terminal whereas ac-A6D-COOH carries two negative
charges at the C-terminal). These results suggest that peptide
nanovesicles can be used for encapsulation and controlled
release of hydrophilic compounds.
Hydrophobic Molecule Uptake and Release through
Peptide Nanovesicles. We next studied the hydrophobic
character of the peptide nanovesicle bilayer using Nile red as
probe molecule, which is hydrophobic and often used to assess
liposome bilayer stability.25 The ﬂuorescence emitted by Nile
red in water is weak and shows maximum at ∼660 nm. The
intensity increases and the emission maximum is blue shifted
when Nile red is buried in a hydrophobic environment shielded
from the polar solvent.25 Figure 4B, inset, shows the emission
spectra of Nile red incorporated into lipid-like peptide
nanovesicles. Depending on the peptide formulation emission
maxima were observed between 621 and 633 nm, which
suggests that assembly of the peptides’ hydrophobic tails results
in the formation of a bilayer with hydrophobic properties. The
ﬂuorescence intensity was higher in the case of Nile red
Table 1. Size of Individual Lipid-Like Peptide Nanovesicles, Peptide Nanovesicle Necklace-Like Formations and Peptide
Nanovesicle Clusters As Determined by AFM (Dry State) and DLS Curve Fitting (Solution)
AFM analysis DLS analysis
peptide vesicle diam. (nm) necklace diam. (nm) cluster diam. (nm) particle diam. (nm)
ac-A6K-CONH2 126 ± 23 122 (30−173)
KA6-CONH2 169 ± 29 164 (65−350)
ac-A6D-COOH 28 ± 9 200 ± 11 113 ± 26 99 (40−320)
DA6-COOH 44 ± 11 159 ± 26 135 ± 24 137 (70−690)
Figure 3. Inverse Laplace transform analysis of the time correlation
functions of lipid-like peptide nanovesicles in PBS. Open circles,
experimental data; solid lines, best ﬁt curve obtained by inverse
Laplace transform; solid squares, volume distributions of the
hydrodynamic radii. The hydrodynamic diameters for each distribution
are also shown. Figure 4. Release kinetics of (A) carboxyﬂuorescein, CF and (B) Nile
red through (●) ac-A6K-CONH2, (▲) KA6-CONH2, (⧫) ac-A6D-
COOH and (■) DA6-COOH peptide nanovesicles in PBS. (B Inset)
Nile Red emission spectra upon interaction with the lipid-like peptide
bilayer in PBS. All data points represent the average of four samples.
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interacting with ac-A6D-COOH nanovesicles compared to that
emitted by Nile red incorporated in ac-A6K-CONH2 nano-
vesicles. This result suggests that the ac-A6D-COOH bilayer
accommodated more Nile red molecules with better shielding
from water compared to Nile red inside the ac-A6K-CONH2
bilayer. Ac-A6D-COOH and ac-A6K-CONH2 have similar
CMCs and therefore, the observed diﬀerences in the emitted
ﬂuorescence of nanovesicle incorporated Nile red is likely due
to better packing of the ac-A6D-COOH peptide monomers in
the bilayer. This results in the presentation of a more
hydrophobic environment for incorporating Nile red in the
ac-A6D-COOH bilayer compared to the ac-A6K-CONH2
bilayer. The ﬂuorescence intensity of Nile red interacting
with KA6-CONH2 and DA6-COOH nanovesicles was signiﬁ-
cantly lower suggesting less Nile red incorporation in these
peptides’ bilayers. Furthermore, we studied the release kinetics
through peptide nanovesicles, and we found slow Nile red
release through ac-A6D-COOH and ac-A6K-CONH2 nano-
vesicles reaching signiﬁcant levels after 6 and 4 h, respectively
(Figure 4B). KA6-CONH2 and DA6-COOH nanovesicles
appeared to be less stable and released Nile red within 2 and
1 h, respectively. Notably, the release kinetics of Nile red
through the peptide nanovesicles follow the order of Nile red
ﬂuorescence emission incorporated inside the hydrophobic
environment of the peptide bilayer (Figure 4B and inset). As in
the case of CF release, we observed that ac-A6K-CONH2 and
ac-A6D-COOH nanovesicles retain Nile red for prolonged
periods of time suggesting that these peptide nanovesicles can
be used for sustained delivery of hydrophilic and hydrophobic
compounds.
Cell Viability. To determine the eﬀect of lipid-like peptides
on Caco-2 cell viability, we used the MTT assay. Figure 5
shows a constant increase in cell numbers after 3 and 24 h
incubation with and without 0.2 or 1.0 mg/mL lipid-like
peptides (P < 0.05). These results suggest that ac-A6K-CONH2,
KA6-CONH2, ac-A6D-COOH, and DA6-COOH lipid-like
peptides do not aﬀect Caco-2 cell proliferation compared
with the control.
■ CONCLUSIONS
Lipid-like peptides were designed to mimic natural lipids having
a hydrophilic head and a hydrophobic domain. Although all
peptides form nanovesicles some of them do not retain model
drug probe molecules for prolonged times. Peptide design by
altering amino acid sequence and charge distribution provides a
means to control the loading capacity and the drug release
kinetics through the nanovesicles. Of the two leading lipid-like
peptide nanovesicle systems (i.e., ac-A6K-CONH2 and ac-A6D-
COOH), the latter may be more suitable for drug delivery.
Negatively charged drug carriers, such as the ac-A6D-COOH
nanovesicles, are preferable for intravenous administration
because they result in electrostatic repulsions with the like-
charged surface of blood cells and vessel walls, which allows for
prolonged circulation in the bloodstream.
Liposomes were proposed as drug delivery carriers in the
1970s. A signiﬁcant amount of work has been done to increase
liposomal stability in serum, prolong drug release and reduce
side eﬀects associated with immunogenicity and toxicity of
liposomes. Lipid-like peptides are nontoxic, nonimmunogenic
and may encapsulate or incorporate and slowly release both
hydrophilic and hydrophobic drug molecules and may present a
platform to append to existing liposomal drug release systems.
Peptide self-assembly is similar to that of lipids and fatty
acids. However, peptides diﬀer from these systems because the
peptide bilayer is stabilized by a combination of hydrophobic
interactions of the hydrophobic amino acids’ side groups and
hydrogen bonding of the peptides’ polar backbones. Therefore,
the bilayer’s internal chemistry diﬀers between liposomes and
peptide nanovesicles. However, lipid-like peptides readily mix
with lipids to form hybrid peptide/lipid liposome systems.26
The incorporation of lipid-like peptides in liposomes conferred
functionality and modulated the liposome bilayer curvature and
stability of the formulation. Furthermore, lipid-like peptides can
be easily modiﬁed and tailored to incorporate other molecules
such as sugars and functional motifs, including cell signaling
and cell penetrating peptides to allow the synthesis of cell
targeting drug delivery systems.
Depending on their sequence peptide nanovesicles can retain
and slowly release both hydrophilic and hydrophobic
compounds. We believe that these simple, inexpensive, and
nontoxic peptides will open new paths in the ﬁeld of vesicle-
mediated drug delivery systems.
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Figure 5. Eﬀect of 0.2 and 1.0 mg/mL lipid-like peptides on Caco-2
cell viability after (A) 3 h and (B) 24 h in culture. In each box chart,
the bottom (×) shows the minimum value and marks the 0th
percentile. The bottom of the box marks the 25th percentile and the
top of the box marks the 75th percentile. The square symbol (□) in
the box marks the mean. The top (×) shows the maximum value and
100th percentile. n = 4 sample points. The diﬀerences in the number
of viable cells at each condition compared to the control are signiﬁcant
(P < 0.05).
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